ALXO
Alx Oncology Holdings
NASDAQ: ALXO · HEALTHCARE · BIOTECHNOLOGY
$1.70
+7.59% today
Updated 2026-04-30
Market cap
$212.60M
P/E ratio
—
P/S ratio
5,085.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$4.60
+170.59%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-19.03M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-123.48M | $-160.81M | $-134.85M | $-101.69M | $-22.85M |
| EPS | — | — | — | — | $-1.90 |
| Free cash flow | $-90.65M | $-131.64M | $-122.36M | $-84.35M | $-19.03M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Alx Oncology Holdings trades at $1.70. Our Smart Value Score of 17/100 indicates the stock is weak.
Frequently asked questions
What is Alx Oncology Holdings 's stock price?
Alx Oncology Holdings (ALXO) trades at $1.70.
Is Alx Oncology Holdings overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of Alx Oncology Holdings (ALXO)?
The analyst target price is $4.60, representing +170.6% upside from the current price of $1.70.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5,085.96x
ROE-145.70%
Beta0.50
50D MA$2.00
200D MA$1.50
Shares out0.13B
Float0.10B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—